(Q53391828)

English

Higher expression of androgen receptor is a significant predictor for better endocrine-responsiveness in estrogen receptor-positive breast cancers.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22231421%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Higher expression of androgen receptor is a significant predictor for better endocrine-responsiveness in estrogen receptor-positive breast cancers (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22231421%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22231421%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Seho Park

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22231421%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Hyung Seok Park

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22231421%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Woo Ick Yang

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22231421%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Seung Il Kim

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22231421%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Byeong-Woo Park

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22231421%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

language of work or name

0 references

publication date

10 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22231421%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22231421%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

133

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22231421%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22231421%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

311-320

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22231421%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

https://scigraph.springernature.com/pub.10.1007/s10549-011-1950-z

0 references

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1950-Z

21 January 2018

Overcoming endocrine resistance in breast cancer: are signal transduction inhibitors the answer?

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1950-Z

21 January 2018

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1950-Z

21 January 2018

Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1950-Z

21 January 2018

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1950-Z

21 January 2018

A gene-expression signature as a predictor of survival in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1950-Z

21 January 2018

Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1950-Z

21 January 2018

Hormone receptor-positive early breast cancer: controversies in the use of adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1950-Z

21 January 2018

Increasing steroid hormone receptors expression defines breast cancer subtypes non responsive to preoperative chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1950-Z

21 January 2018

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1950-Z

21 January 2018

Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1950-Z

21 January 2018

Androgen receptor expression and breast cancer survival in postmenopausal women

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1950-Z

21 January 2018

Expression of androgen receptors in primary breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1950-Z

21 January 2018

Combination hormonal therapy with tamoxifen plus fluoxymesterone versus tamoxifen alone in postmenopausal women with metastatic breast cancer. An updated analysis

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1950-Z

21 January 2018

Role of androgens on MCF-7 breast cancer cell growth and on the inhibitory effect of letrozole

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1950-Z

21 January 2018

Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1950-Z

21 January 2018

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1950-Z

21 January 2018

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1950-Z

21 January 2018

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1950-Z

21 January 2018

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1950-Z

21 January 2018

A 2009 update on the treatment of patients with hormone receptor-positive breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1950-Z

21 January 2018

Expression of androgen receptor in breast cancer and its significance as a prognostic factor

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1950-Z

21 January 2018

Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1950-Z

21 January 2018

The impact of primary tumor size, lymph node status, and other prognostic factors on the risk of cancer death

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1950-Z

21 January 2018

The predictive role of E-cadherin and androgen receptor on in vitro chemosensitivity in triple-negative breast Cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1950-Z

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53391828&oldid=1958358495"